Iconocast Logo

Welcome To Iconocast

How to add a URL link from your web site to the Iconocast web sites

Virtual tour of Southern California



 

Recent News and Articles on the Keywords: osteosarcoma + 1,330,000 + osteosarcoma:  Related to the article below (Last Update: 8/5/2008)

Bouncing back after cancer
Hindustan Times, India - Aug 2, 2008
Vertika was getting treatment for osteosarcoma (cancer of the bone tissue) and a prosthesis (artificial device used to replace a missing body part) implant ...

The Columbian
Blog details teen's cancer fight
The Columbian, WA - Aug 3, 2008
Since February, Elizabeth Rowan, 17, and her dad, Rod Rowan, have been blogging about her journey with osteosarcoma ? a type of bone cancer ? at ...
New Video Entitled "Osteosarcoma of Proximal Humerus" Added to ...
PR Web (press release), WA - Jul 27, 2008
New York, NY (PRWEB) July 27, 2008 -- Sarcoma surgeon Dr. James C. Wittig introduces his newest surgical video, Osteosarcoma of Proximal Humerus, ...
... Go to the Article
CancerWise - Aug 1, 2008
Researchers added MS-275 to human NK cells and osteosarcoma cells. Osteosarcoma is the most common pediatric bone cancer. The addition of MS-275 made ...
Bold cancer therapy begins crucial trials: In human test, world may Small Times
all 2 news articles »

Ortho SuperSite
Low-grade Intramedullary Osteosarcoma of the Tibia Presenting as ...
Ortho SuperSite, NJ - Jul 22, 2008
By Janet Sailor, MD; Edward F. McCarthy, MD; Kristy L. Weber, MD; Laura M. Fayad, MD Intramedullary or intraosseous osteosarcomas are the most common ...

NECN
NECN pedal partner Caroline, at the PMC kickoff
NECN, MA - Aug 1, 2008
At the age of 7, Caroline Lane was diagnosed with osteosarcoma, cancer of the bone. There are about 900 new cases in the United States each year -- about ...
Kerry rides in PMC to honor Kennedy NECN
all 2 news articles »

NECN
Caroline Lane is Team NECN's pedal partner
NECN, MA - Aug 1, 2008
(Ally Donnelly, NECN) - 2008 NECN pedal partner in the Pan Mass Challenge Caroline Lane was diagnosed with osteosarcoma, a cancer of the bone in -- for the ...
Cluster or Coincidence? Teens Share Same Rare Cancer
FOXNews - Jul 8, 2008
Four Pocono Mountain-area teenagers have been diagnosed with osteosarcoma since 2006 ? and their families want to know if the cancers are a result of a ...

Send2Press (press release)
Epeius Biotechnologies' Tumor-Targeted Rexin-G Receives FDA Orphan ...
Send2Press (press release), CA - Jul 8, 2008
Based on several criteria, including the rarity, seriousness, and current lack of effective therapies for metastatic osteosarcoma, as well as the scientific ...
FDA Grants Epeius Biotechnologies' Rexin-GA Third Orphan Drug ... Send2Press (press release)
all 17 news articles »
8000 People Join The Team Sarcoma Initiative To Fight A Rare Cancer
Medical News Today (press release), UK - 30 minutes ago
Lori Brasic's son, Logan, is in treatment for osteosarcoma, and she organized "Soccer 'Round the Clock" in Jackson, MI. Her words capture the poignancy of ...
Source: Google News

A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma -
SH Friend, R Bernards, S Rogelj, RA Weinberg, JM … - Nature, 1986 - nature.com
... 10.1038/323643a0. A human DNA segment with properties of the gene that predisposes
to retinoblastoma and osteosarcoma. Stephen H. Friend ...

… of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity. -
MP Link, AM Goorin, AW Miser, AA Green, CB Pratt, … - N Engl J Med, 1986 - ncbi.nlm.nih.gov
N Engl J Med. 1986 Jun 19;314(25):1600-6. The effect of adjuvant chemotherapy on
relapse-free survival in patients with osteosarcoma of the extremity. ...

Estrogen binding, receptor mRNA, and biologic response in osteoblast-like osteosarcoma cells -
BS Komm, CM Terpening, DJ Benz, KA Graeme, A … - Science, 1988 - sciencemag.org
... 1988 Estrogen Binding, Receptor mRNA, and Biologic Response in Osteoblast-
Like Osteosarcoma Cells ... rat and human osteosarcoma celis. ...

Treatment of nonmetastatic osteosarcoma of the extremity with preoperative and postoperative … -
AJ Provisor, LJ Ettinger, JB Nachman, MD Krailo, … - Journal of Clinical Oncology, 1997 - jco.ascopubs.org
... ARTICLES. Treatment of nonmetastatic osteosarcoma of the extremity with preoperative
and postoperative chemotherapy: a report from the Children's Cancer Group. ...

… trial of two regimens of chemotherapy in operable osteosarcoma: a study of the European Osteosarcoma -
RL Souhami, M Nooy, J van der Eijken, V Bramwell, … - Proc. Am. Soc. Clin. Oncol, 1996 - asco.org
... A randomized trial of two regimens of chemotherapy in operable osteosarcoma: a study
of the European Osteosarcoma Intergroup (EOI) (Meeting abstract). ...
-

MDM2 gene amplification in metastatic osteosarcoma -
M Ladanyi - Cancer Research, 1993 - AACR
... ARTICLES. MDM2 gene amplification in metastatic osteosarcoma. ... None of the primary
osteosarcoma specimens had detectable MDM2 gene amplification. ...

Neoadjuvant chemotherapy of osteosarcoma: results of a randomized cooperative trial (COSS-82) with … -
K Winkler, G Beron, G Delling, U Heise, H Kabisch, … - Journal of Clinical Oncology, 1988 - jcojournal.org
... Neoadjuvant chemotherapy of osteosarcoma: results of a randomized cooperative trial
(COSS-82) with salvage chemotherapy based on histological tumor response. ...

Adjuvant chemotherapy for osteosarcoma: a randomized prospective trial -
F Eilber, A Giuliano, J Eckardt, K Patterson, S … - Journal of Clinical Oncology, 1987 - jcojournal.org
... ARTICLES. Adjuvant chemotherapy for osteosarcoma: a randomized prospective trial. ...
Extraosseous Osteosarcoma: Response to Treatment and Long-Term Outcome J. Clin. ...

FBJ murine osteosarcoma virus: identification and molecular cloning of biologically active proviral … -
T Curran, G Peters, C Van Beveren, NM Teich, IM … - Journal of Virology, 1982 - pubmedcentral.nih.gov
... 1982 November; 44(2): 674?682. Copyright notice. FBJ murine osteosarcoma virus:
identification and molecular cloning of biologically active proviral DNA. ...

osteosarcoma of limbs in children and young adults: the first study of the European Osteosarcoma -
VH Bramwell, M Burgers, R Sneath, R Souhami, AT … - Journal of Clinical Oncology, 1992 - jco.ascopubs.org
... A comparison of two short intensive adjuvant chemotherapy regimens in operable
osteosarcoma of limbs in children and young adults: the first study of the ...

Source: Google Scholar
 

Osteosarcoma

Osteosarcoma is the most common of three types of bone cancer. It develops in the new tissue of growing bones usually during adolescence. The other types of bone cancer are chondrosarcoma, which arises in cartilage, and Ewing's sarcoma, which may arise in immature nerve tissue in the bone marrow.

Osteosarcoma is the sixth most common type of cancer in children. It is one of the few types of cancers that begin in the bone and can spread to other parts of the body. (Many types of cancer begin elsewhere in the body and spread to the bones.)

Symptoms of Osteosarcoma

Osteosarcoma is marked by:

  • Pain the bone that is sometimes worse at night or during exercise and isn't helped by pain relievers
  • A lump or swelling in a child's arm or leg that develops up to several weeks after the pain. This usually occurs in the longer bones of the body.
  • An unexplained limp
  • Unexplained bone fractures
  • Fatigue
  • Fever
  • Weight loss
  • Anemia

Article continues below and (thank you)

 
Causes and Risk Factors for Osteosarcoma

Osteosarcoma is caused by genetic errors that occur during times of intense bone growth. It usually develops from osteoblasts, the cells that make bone grow. As a result, it usually affects teens who are having a growth spurt. People who develop osteosarcoma are typically between the ages of 10 and 25.

Most often, osteosarcoma involves the knee. It usually is found in the growing ends of the bones, the metaphysis.

Boys are more likely to develop osteosarcoma than girls. There is some evidence showing that teens who are taller than average have a greater risk of developing osteosarcoma.

Children who have inherited one of the rare cancer syndromes such as retinoblastoma or Li-Fraumeni also have a higher risk of developing osteosarcoma. Because radiation can trigger genetic mutations, children who have received radiation treatment for cancer have a greater risk of developing osteosarcoma.

There is no evidence that an injury can cause osteosarcoma to develop.

Diagnosing Osteosarcoma

Your child's doctor will take a detailed medical and family history and do a physical examination. He or she may also order:

  • A blood test. Bone tumors are often associated with increases levels of certain enzymes in the blood.
  • An X-ray to detect any changes in the bone
  • A computed tomography (CT) scan. This will also help identify the best place to take a sample of bone (a biopsy) for examination under a microscope.
  • A bone biopsy. This can be done either using a hollow needle to take a sample of the bone or by doing surgery under a general anesthesia. After the sample is taken, it will be examined by a specialist (a pathologist), who will determine whether the cells are cancer and, if so, what type of cancer.
  • Magnetic resonance imaging (MRI)

If these tests indicate the presences of osteosarcoma, your doctor will order CT scans of your child's chest as well as a bone scan. More MRI studies may also be ordered. These are needed to show whether the cancer has spread to other parts of the body. In addition, these tests may be repeated during treatment to see how treatment is working and whether the cancer has spread.

Treating Osteosarcoma

Because osteosarcoma can spread, even when a tumor is caught early, treatment focuses on the whole body. Treatment may include:

  • Chemotherapy. This uses chemical to kill or shrink the tumor cells that may have spread. Chemotherapy may be used before or after (or both) surgery. It has both short- and long-term side effects including anemia, an increase risk of infections, abnormal bleeding, destruction of the bone marrow, kidney or liver damage, hearing loss or skin or heart problems.
  • Surgery to remove the bone tumor. This involves removing cancerous cells or tumors and repairing the gap left behind in the bone. The gap is filled by a bone graft, usually from the child's own hipbone (pelvis).
  • Surgery to remove a limb affected by osteosarcoma. Amputation may be the only option if the cancer has spread to nearby nerves and blood vessels. After amputation, it may take a child three to six months to learn to use an artificial arm or leg. In addition, psychological and social rehabilitation may be needed.
  • Surgery to remove tumors in other parts of the body that have spread from the bone tumor.
  • Radiation therapy, which uses high doses of X-rays to kill cancer cells

How effective treatment is depends on several factors:

  • How large the tumor is
  • Whether the cancer spread from the bones to other parts of the body. There is a 60% to 80% survival rate for patients receiving treatment for osteosarcoma that has not spread.
  • Where the tumor is located. Outcomes are generally better if the affected bone is in an arm or leg. When the affected bone is in the ribs, shoulder blades, spine or hipbone, outcomes are not as good.
 
 
 
Google
Web www.iconocast.com
 
 
ALL THE NEWS : News1 ; News2 ; News3 ; News4 ; News5 ; News6 ; News7 ; News8 ; News9 ; News9A


ADVERTISEMENT

Iconocast is about learning and teaching without borders; we offer eMarketing, Internet Advertising, Internet Marketing, Search Engine Optimization, Search Engine Marketing, Online Branding, and eMarketing News Services.

 

Iconocast Home Page

 © 2002-2006

Keywords:

Contact Iconocast